09.08.2021 08:00:00

DSM announces repurchase of shares to cover stock dividend

HEERLEN, Netherlands, Aug. 9, 2021 /PRNewswire/ -- Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, today announces the repurchase of 250,000 ordinary shares to cover commitments for interim stock dividend 2021, equivalent to approximately €43 million based on the closing price of the DSM share on Euronext Amsterdam on 6 August 2021.

DSM Logo.

The share buyback will be executed within the limitations of the authority granted to the Managing Board by the Annual General Meeting (AGM) on 6th May 2021. The total number of shares to be repurchased under this program represents approximately 0.14% of ordinary shares issued.

DSM has signed a Discretionary Management Agreement with a bank to commence the execution on its behalf and to make trading decisions under the Agreement independently of DSM.

In accordance with regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases. The share repurchase program is anticipated to be completed in August 2021.

DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. Our products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large.

DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees.

The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Or find us on:

Facebook: https://www.facebook.com/DSMcompany
Twitter: https://www.twitter.com/DSM
LinkedIn: https://www.linkedin.com/company/3108 
YouTube: https://www.youtube.com/user/dsmcompany 

For more information:

DSM Media relations

Lieke de Jong

tel. +31 (0) 45 5782420

email media.contacts@dsm.com

DSM Investor Relations

Dave Huizing

tel. +31 (0) 45 5782864

email investor.relations@dsm.com 

Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Logo - https://mma.prnewswire.com/media/329419/dsm_logo.jpg

Nachrichten zu Koninklijke DSM NV (spons. ADRs)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Koninklijke DSM NV (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!